Kawakami H - Search Results

1

MET amplification as a potential therapeutic target in gastric cancer.

Kawakami H, Okamoto I, Arao T, Okamoto W, Matsumoto K, Taniguchi H, Kuwata K, Yamaguchi H, Nishio K, Nakagawa K, Yamada Y. Kawakami H, et al. Oncotarget. 2013 Jan;4(1):9-17. doi: 10.18632/oncotarget.718. Oncotarget. 2013. PMID: 23327903 Free PMC article.

2

Human epidermal growth factor eyedrops for cetuximab-related filamentary keratitis.

Kawakami H, Sugioka K, Yonesaka K, Satoh T, Shimomura Y, Nakagawa K. Kawakami H, et al. J Clin Oncol. 2011 Aug 10;29(23):e678-9. doi: 10.1200/JCO.2011.35.0694. Epub 2011 Jun 20. J Clin Oncol. 2011. PMID: 21690478 No abstract available.

3

[A review of FOLFOXIRI chemotherapy for the 1st line treatment of metastatic colorectal cancer].

Kawakami H, Satoh T, Nakagawa K. Kawakami H, et al. Nihon Rinsho. 2011 Apr;69 Suppl 3:439-45. Nihon Rinsho. 2011. PMID: 22214001 Review. Japanese. No abstract available.

4

Clinical outcome for EML4-ALK-positive patients with advanced non-small-cell lung cancer treated with first-line platinum-based chemotherapy.

Takeda M, Okamoto I, Sakai K, Kawakami H, Nishio K, Nakagawa K. Takeda M, et al. Among authors: kawakami h. Ann Oncol. 2012 Nov;23(11):2931-2936. doi: 10.1093/annonc/mds124. Epub 2012 Jul 5. Ann Oncol. 2012. PMID: 22771825 Free article.

5

Capecitabine plus Cisplatin treatment for advanced gastric cancer in a patient with hepatic impairment secondary to metastases.

Kawakami H, Nishina S, Ueda S, Kudo T, Okamoto W, Kurata T, Okamoto I, Nakagawa K. Kawakami H, et al. Gastrointest Cancer Res. 2012 May;5(3):103-5. Gastrointest Cancer Res. 2012. PMID: 22888392 Free PMC article. No abstract available.

6

Phase I trial of OTS11101, an anti-angiogenic vaccine targeting vascular endothelial growth factor receptor 1 in solid tumor.

Hayashi H, Kurata T, Fujisaka Y, Kawakami H, Tanaka K, Okabe T, Takeda M, Satoh T, Yoshida K, Tsunoda T, Arao T, Nishio K, Nakagawa K. Hayashi H, et al. Among authors: kawakami h. Cancer Sci. 2013 Jan;104(1):98-104. doi: 10.1111/cas.12034. Epub 2012 Nov 8. Cancer Sci. 2013. PMID: 23020774 Free PMC article. Clinical Trial.

7

Postprogression survival for first-line chemotherapy in patients with advanced gastric cancer.

Kawakami H, Okamoto I, Hayashi H, Taguri M, Morita S, Nakagawa K. Kawakami H, et al. Eur J Cancer. 2013 Sep;49(14):3003-9. doi: 10.1016/j.ejca.2013.05.022. Epub 2013 Jun 20. Eur J Cancer. 2013. PMID: 23791540

8

Phase I pharmacokinetic study of S-1 granules and nedaplatin for advanced head and neck cancer.

Hayashi H, Okamoto I, Ueda S, Tanaka K, Okamoto K, Kawakami H, Nishina S, Takeda M, Fujisaka Y, Satoh T, Terao K, Nishimura Y, Doi K, Nakagawa K. Hayashi H, et al. Among authors: kawakami h. Anticancer Res. 2013 Dec;33(12):5699-705. Anticancer Res. 2013. PMID: 24324120 Clinical Trial.

9

Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma.

Kawakami H, Okamoto I, Terao K, Sakai K, Suzuki M, Ueda S, Tanaka K, Kuwata K, Morita Y, Ono K, Nishio K, Nishimura Y, Doi K, Nakagawa K. Kawakami H, et al. Cancer Med. 2013 Dec;2(6):933-41. doi: 10.1002/cam4.151. Epub 2013 Oct 27. Cancer Med. 2013. PMID: 24403267 Free PMC article.

10

Inhibition of EGFR, HER2 and HER3 signaling with AZD8931 alone and in combination with paclitaxel: phase i study in Japanese patients with advanced solid malignancies and advanced breast cancer.

Kurata T, Tsurutani J, Fujisaka Y, Okamoto W, Hayashi H, Kawakami H, Shin E, Hayashi N, Nakagawa K. Kurata T, et al. Among authors: kawakami h. Invest New Drugs. 2014 Oct;32(5):946-54. doi: 10.1007/s10637-014-0112-7. Epub 2014 May 31. Invest New Drugs. 2014. PMID: 24875132 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,460 results

Search Page